Latest Insider Transactions at Bausch & Lomb Corp (BLCO)
This section provides a real-time view of insider transactions for Bausch & Lomb Corp (BLCO). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Bausch & Lomb Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Bausch & Lomb Corp's insiders and make more informed investment decisions.
Insider Transaction List
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
May 10
2022
|
Nathalie D. Bernier Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,500
+50.0%
|
-
|
May 10
2022
|
Bausch Health Companies Inc. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,000,000
-10.0%
|
$595,000,000
$17.05 P/Share
|
May 05
2022
|
Yehia Hashad EVP of R&D and CMO |
BUY
Grant, award, or other acquisition
|
Direct |
34,722
+50.0%
|
-
|
May 05
2022
|
Sam Eldessouky EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
125,000
+50.0%
|
-
|
May 05
2022
|
Joseph C Papa CEO & Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
472,222
+50.0%
|
-
|
May 05
2022
|
Christina Ackermann Officer |
BUY
Grant, award, or other acquisition
|
Direct |
83,333
+50.0%
|
-
|
May 05
2022
|
Frederick Munsch SVP, Controller and CAO |
BUY
Grant, award, or other acquisition
|
Direct |
22,222
+50.0%
|
-
|
May 05
2022
|
Joseph F Gordon Officer |
BUY
Grant, award, or other acquisition
|
Direct |
69,444
+50.0%
|
-
|